Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 714 of 6351
-
New combo therapy offers hope for cancer patients who Can't breathe
Disease control Recruiting nowThis phase I/II trial studies the side effects of interstitial photodynamic therapy following palliative radiotherapy and how well it works in treating patients with inoperable malignant central airway obstruction. Patients who have advanced stage cancer tumors in the lung can of…
Phase 1/2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New weekly shot helps shed pounds in obesity trial
Disease control CompletedA Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 compared with placebo, given once a week as subcutaneous injection for 36 weeks, in male and female participants of at least 18 years of age who are living …
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New cocktail of four drugs hopes to fight Hard-to-Treat bile duct cancer
Disease control Recruiting nowThis is a multicenter Phase 1b/2 clinical trial investigating the efficacy and safety of a combination regimen of Gemcitabine, Cisplatin, Nab-paclitaxel, and Tislelizumab in treatment-naïve patients with unresectable, locally advanced, or metastatic biliary tract cancers (BTC), i…
Sponsor: CHA University • Aim: Disease control
Last updated Jun 26, 2026 16:55 UTC
-
Can a new injection breathe life into COPD treatment?
Disease control CompletedThis multicentre retrospective cohort study describes lung function and patient-reported outcomes in adults with chronic obstructive pulmonary disease (COPD) and type 2 inflammation who received add-on dupilumab in routine clinical care at six Italian centres. During the study p…
Sponsor: Azienda Ospedaliera di Perugia • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a new test cut unnecessary biopsies for HPV-Positive women?
Diagnosis OngoingA prospective study assessing TS accuracy in HR-HPV+ women, influencing factors, and 1-year follow-up of false-positives versus biopsy.
Sponsor: Affiliated Hospital of Nantong University • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
New hope for adults with HLH: gentler treatment combo under study
Disease control Recruiting nowThis phase II trial tests the effects of ruxolitinib in combination with a de-intensified HLH-94 drug regimen has on patients with newly diagnosed hemophagocytic lymphohistiocytosis (HLH), a disorder caused by dysregulated immune responses (that is, immune responses that are too …
Phase 2 • Sponsor: Jerry Lee, MD, MSc, MPhil • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New Immunotherapy-Chemo combo aims to tackle rare sarcoma
Disease control Recruiting nowSoft tissue sarcoma (STS) is a rare, highly heterogeneous malignancy with a poor prognosis. The standard first-line treatment for advanced patients is anthracyclines (doxorubicin, A) combined with ifosfamide (I, AI regimen), but the efficacy is limited, and some subtypes do not r…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New heart procedure aims to stop persistent AFib in its tracks
Disease control OngoingPulsed field ablation (PFA) has demonstrated favorable safety and efficacy in atrial fibrillation ablation, particularly for pulmonary vein isolation (PVI). However, the optimal PFA-based ablation strategy for non-paroxysmal atrial fibrillation remains uncertain. In addition to a…
Sponsor: Xu Liu • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a Three-Drug cocktail shrink stomach tumors before surgery?
Disease control OngoingFor locally advanced gastric and gastroesophageal junction adenocarcinoma (cT3-4bNanyM0), perioperative PD-1 antibody combined with chemotherapy can downstage tumor stage, increase the R0 resection rate, and may improve the long-term survival. Combination of perioperative surufat…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a drop of bone cement keep hip fracture repairs from failing?
Disease control Recruiting nowThe goal of this clinical trial is to learn if small modifications in the surgical technique for the treatment of some kind of hip fractures, improve the result of the surgery. This small modification includes the addition of surgical bone cement to part of the intramedullary nai…
Sponsor: Diego Matías Domínguez Prado • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New asthma drug could help patients ditch their daily inhalers
Disease control OngoingThe objective of this study is to assess the potential for tezepelumab-treated patients (subcutaneous administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma.. Study details include: 1. The study duration will be …
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo aims to stop lymphoma relapse after powerful treatments
Disease control OngoingThis phase II trial tests how well pembrolizumab and tazemetostat work to treat patients who have received autologous stem cell transplantation (ASCT) or chimeric antigen receptor (CAR) T cell therapy for aggressive non hodgkins lymphoma. A monoclonal antibody, such as pembrolizu…
Phase 2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug combo shows promise for early anal cancer
Disease control Recruiting nowA single arm phase II study of pembrolizumab, carboplatin, paclitaxel, and radiation for the treatment of early-stage anal cancer. There are 2 treatments phases and then surveillance. The first treatment phase is the chemoradiation phase (Cycle 1-6, weekly cycles) which is follow…
Phase 2 • Sponsor: Dustin Deming • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Double attack on Alzheimer's: new drug combo targets tau and amyloid
Disease control OngoingThe primary objective of the study is to determine the dose response of E2814, when concurrently administered with lecanemab, on the change from baseline at 6 months in cerebrospinal fluid (CSF) microtubule-binding region (MTBR)-tau-243 in participants with early Alzheimer's dise…
Phase 2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy offers hope for hard-to-treat stomach cancer
Disease control Recruiting nowDespite recent advances, the prognosis of patients with advanced gastric cancer remains poor. At present, regimens that combine a platinum and fluorouracil agent either alone or in combination with a third drug such as epirubicin or taxane constitute the most effective treatment …
Phase 1/2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a new vaccine bolster defenses against COVID-19?
Vaccine CompletedA First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers
Phase 1 • Sponsor: Rock BioMedical, Inc. • Aim: Vaccine
Last updated Sep 04, 2026 00:00 UTC
-
New combo therapy targets both psoriasis and obesity in major trial
Disease control CompletedThe main purpose of this study is to demonstrate that when participants with moderate to severe plaque psoriasis and obesity or overweight in the presence of at least 1 weight-related comorbid condition receive ixekizumab and tirzepatide concomitantly administered, participants s…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Social media ban on teen phones tested in landmark experiment
Knowledge-focused Recruiting nowThe mental health of adolescents in the United States has seen a steep decline, roughly coinciding with the increasing popularity of social media and smartphones. But does social media have a causal impact on the mental health of adolescents or are concerns about the effect of so…
Sponsor: Georgetown University • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Radiation and immunotherapy combo before lung cancer surgery shows promise in early trial
Disease control Stopped earlyThe Window-of-Opportunity (WOO) Network is a collaboration among Ontario's doctors and scientists to conduct clinical trials in newly-diagnosed cancer patients before they have surgery with an initial focus on understanding how cancer drugs can impact the immune system. There is…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
A guided path back to work after blood cancer: a trial tests the impact
Symptom relief Recruiting nowReturn to work (RTW) of patients after cancer treatment has been a topic of growing interest for the past two decades. Advances in cancer care have led to better patient survival, with some cancers considered as chronic or even cured diseases. The return of patients to their "pre…
Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC